StockNews.com initiated coverage on shares of ClearOne (NASDAQ:CLRO – Free Report) in a research report report published on Saturday morning. The firm issued a hold rating on the communications equipment provider’s stock.
ClearOne Stock Performance
CLRO stock opened at $0.62 on Friday. The firm has a 50 day moving average price of $0.61 and a 200-day moving average price of $0.86. ClearOne has a 52-week low of $0.53 and a 52-week high of $2.48. The firm has a market capitalization of $14.86 million, a price-to-earnings ratio of -8.86 and a beta of 0.80.
ClearOne (NASDAQ:CLRO – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The communications equipment provider reported ($0.12) earnings per share for the quarter. The firm had revenue of $2.30 million for the quarter. ClearOne had a negative net margin of 22.89% and a negative return on equity of 19.94%.
Institutional Investors Weigh In On ClearOne
About ClearOne
ClearOne, Inc, together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally. The company offers a range of audio conferencing products, including professional audio conferencing and sound-reinforcement products for use in enterprise, healthcare, education and distance learning, government, legal, and finance organizations; mid-tier premium conferencing products for smaller rooms, and small and medium businesses, which interface with video and Web conferencing systems; USB-based personal and group speakerphones that could be used with PCs, laptops, tablets, smartphones, and other portable devices; and traditional tabletop conferencing phones used in conference rooms and offices.
See Also
- Five stocks we like better than ClearOne
- The 3 Best Fintech Stocks to Buy Now
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Using the MarketBeat Dividend Tax Calculator
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for ClearOne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearOne and related companies with MarketBeat.com's FREE daily email newsletter.